Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
Titel:
Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
Auteur:
Cazzaniga, M. E. Cortesi, L. Ferzi, A. Scaltriti, L. Cicchiello, F. Ciccarese, M. Della Torre, S. Villa, F. Giordano, M. Verusio, C. Nicolini, M. Gambaro, A. R. Zanlorenzi, L. Biraghi, E. Legramandi, L. Rulli, E.